A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 455 participants.
Also called NCT05333835
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 455 participants
- Registry
-
NCT05333835
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05333835. Randomized; no masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2024-03-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HR17031 injection
- Intervention (Drug)
- INS068 injection
- Intervention (Drug)
- SHR20004 injection
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct05333835- Content hash
21f35c30fed118a7c170a0970954144216d32b56556de78ccb485fe747fac309